Magnetic resonance angiography for the primary diagnosis of pulmonary embolism: A review from the international workshop for pulmonary functional imaging by Tsuchiya, N. et al.
This is a repository copy of Magnetic resonance angiography for the primary diagnosis of 
pulmonary embolism: A review from the international workshop for pulmonary functional 
imaging.
White Rose Research Online URL for this paper:
http://eprints.whiterose.ac.uk/135367/
Version: Published Version
Article:
Tsuchiya, N., van Beek, E.J., Ohno, Y. et al. (8 more authors) (2018) Magnetic resonance 
angiography for the primary diagnosis of pulmonary embolism: A review from the 
international workshop for pulmonary functional imaging. World Journal of Radiology , 10 
(6). pp. 52-64. ISSN 1949-8470 
https://doi.org/10.4329/wjr.v10.i6.52
eprints@whiterose.ac.uk
https://eprints.whiterose.ac.uk/
Reuse 
This article is distributed under the terms of the Creative Commons Attribution-NonCommercial (CC BY-NC) 
licence. This licence allows you to remix, tweak, and build upon this work non-commercially, and any new 
works must also acknowledge the authors and be non-commercial. You don’t have to license any derivative 
works on the same terms. More information and the full terms of the licence here: 
https://creativecommons.org/licenses/ 
Takedown 
If you consider content in White Rose Research Online to be in breach of UK law, please notify us by 
emailing eprints@whiterose.ac.uk including the URL of the record and the reason for the withdrawal request. 
Nanae Tsuchiya, Edwin JR van Beek, Yoshiharu Ohno, Hiroto Hatabu, Hans-Ulrich Kauczor, Andrew Swift, 
Jens Vogel-Claussen, Jürgen Biederer, James Wild, Mark O Wielpütz, Mark L Schiebler
REVIEW
52 June 28, 2018|Volume 10|Issue 6|WJR|www.wjgnet.com
Magnetic resonance angiography for the primary diagnosis 
of pulmonary embolism: A review from the international 
workshop for pulmonary functional imaging
Nanae Tsuchiya, Department of Radiology, Graduate School of 
Medical Science, University of the Ryukyus, Okinawa 903-0215, 
Japan
Nanae Tsuchiya, Mark L Schiebler, Department of Radiology, 
University of Wisconsin-Madison, Madison, WI 53792, United 
States
Edwin JR van Beek, Edinburgh Imaging, Queens Medical 
Research Institute, University of Edinburgh, Edinburgh EH16 
4TJ, United Kingdom
Yoshiharu Ohno, Division of Functional and Diagnostic Imaging 
Research, Department of Radiology, Kobe University Graduate 
School of Medicine, Kobe 650-0017, Japan
Hiroto Hatabu, Department of Radiology, Brigham and Womens 
Hospital, Boston, MA 02115, United States 
Hans-Ulrich Kauczor, Mark O Wielpütz, Department of Di-
agnostic and Interventional Radiology, University Hospital of 
Heidelberg, Heidelberg 69120, Germany
Andrew Swift, Department of Radiology, Royal Hallamshire 
Hospital, University of Sheffield, Sheffield S10 2JF, United 
Kingdom
Jens Vogel-Claussen, Department of Radiology, Carl-Neuberg 
Strasse 1, Hannover-Gr-Buchholz 30625, Germany
Jürgen Biederer, Radiology Darmstadt, Gross-Gerau County 
Hospital, Gross-Gerau 64521, Germany
James Wild, Department of Infection, Immunity and Cardi-
ovascular Disease, University of Sheffield, Sheffield S10 2JF, 
United Kingdom
ORCID number: Nanae Tsuchiya (0000-0003-2556-8287); 
Edwin JR van Beek (0000-0002-2777-5071); Yoshiharu Ohno 
(0000-0002-4431-1084); Hiroto Hatabu (0000-0002-6259-0814); 
H a n s - U l r i c h  K a u c z o r  ( 0 0 0 0 - 0 0 0 1 - 7 2 2 4 - 4 7 5 8 ) ; 
Andrew Swif t  (0000-0001-9048-0121);  Jens  Vogel-
Claussen  (0000-0001-5595-6948) ;  Jürgen  Biederer 
(0000-0002-4262-6285); James Wild (0000-0002-7246-8660); 
Mark O Wielpütz (0000-0001-6962-037X); Mark L Schiebler 
(0000-0002-9120-5428).
Author contributions: Tsuchiya N contributed to design of the 
study, literature review and analysis, drafting and critical revision 
and editing, and final approval of the final version; van Beek 
EJR, Hatabu H and Kauczor HU contributed to conception and 
design of the study, drafting and critical revision and editing, and 
final approval of the final version; Ohno Y, Vogel-Claussen J, 
Wild J and Schiebler ML contributed to conception and design 
of the study, literature review and analysis, drafting and critical 
UHYLVLRQDQGHGLWLQJDQG¿QDODSSURYDORIWKH¿QDOYHUVLRQ6ZLIW
A and Wielpütz MO contributed to literature review and analysis, 
drafting and critical revision and editing, and final approval of 
WKH¿QDOYHUVLRQ%LHGHUHU-FRQWULEXWHGWRFRQFHSWLRQRIVWXG\
literature review and analysis, drafting and critical revision and 
HGLWLQJDQG¿QDODSSURYDORIWKH¿QDOYHUVLRQ
&RQÀLFWRILQWHUHVWVWDWHPHQW There are QRFRQÀLFWVRILQWHUHVW
UHODWHGWRWKLVZRUN1R¿QDQFLDOVXSSRUW
Open-Access: This article is an open-access article which was 
selected by an in-house editor and fully peer-reviewed by external 
reviewers. It is distributed in accordance with the Creative 
Commons Attribution Non Commercial (CC BY-NC 4.0) license, 
which permits others to distribute, remix, adapt, build upon this 
work non-commercially, and license their derivative works on 
different terms, provided the original work is properly cited and 
the use is non-commercial. See: http://creativecommons.org/
licenses/by-nc/4.0/
Manuscript source: Invited manuscript
Correspondence to: Mark L Schiebler, MD, Professor, Dep-
artment of Radiology, University of Wisconsin-Madison, 600 
Highland Avenue, Madison, WI 53792, 
United States. mschiebler@uwhealth.org 
Telephone: +1-608-2657250
World Journal of 
RadiologyW J R
Submit a Manuscript: http://www.f6publishing.com
DOI: 10.4329/wjr.v10.i6.52
World J Radiol 2018 June 28; 10(6): 52-64
ISSN 1949-8470 (online)
53WJR|www.wjgnet.com
Tsuchiya N et al . CE-MRA for the primary diagnosis of pulmonary embolism
Fax: +1-608-2631229
Received: January 27, 2018
Peer-review started: January 30, 2018
First decision: March 19, 2018
Revised: April 25, 2018
Accepted: May 30, 2018
Article in press: May 30, 2018
Published online: June 28, 2018
Abstract
Pulmonary contrast enhanced magnetic resonance ang-
iography (CE-MRA) is useful for the primary diagnosis 
of pulmonary embolism (PE). Many sites have chosen 
not to use CE-MRA as a first line of diagnostic tool for 
PE because of the speed and higher efficacy of com-
puterized tomographic angiography (CTA). In this rev-
iew, we discuss the strengths and weaknesses of CE-
MRA and the appropriate imaging scenarios for the 
primary diagnosis of PE derived from our unique multi-
institutional experience in this area. The optimal patient 
for this test has a low to intermediate suspicion for PE 
based on clinical decision rules. Patients in extremis are 
not candidates for this test. Younger women (< 35 years 
of age) and patients with iodinated contrast allergies are 
best served by using this modality We discuss the history 
of the use of this test, recent technical innovations, 
artifacts, direct and indirect findings for PE, ancillary 
findings, and the effectiveness (patient outcomes) of 
CE-MRA for the exclusion of PE. Current outcomes data 
shows that CE-MRA and NM V/Q scans are effective 
alternative tests to CTA for the primary diagnosis of PE.
Key words: Female; Lung; Neoplasms; Hypersensitivity; 
Pulmonary embolism; Magnetic resonance angiography; 
Radiation induced; Outcome assessment (health care); 
Artifacts; Computerized tomography angiography
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Core tip: Pulmonary contrast enhanced magnetic res-
onance angiography (CE-MRA) is an effective alternative 
test for the primary diagnosis of pulmonary embolism 
(PE). In outcomes studies the negative predictive value 
of CE-MRA at 6 mo was 99%, which is similar to the 
negative predictive value of multidetector computerized 
tomographic angiography. The optimal patient selection 
is for younger female patients with a low to intermediate 
risk of PE or those with iodinated contrast allergies. 
Tsuchiya N, van Beek EJR, Ohno Y, Hatabu H, Kauczor 
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INTRODUCTION
Acute pulmonary embolism (PE) affects 0.1% of the 
population annually and is associated with significant 
morbidity and mortality
[1,2]
. Common symptoms of PE 
are acute chest pain and dyspnea. When the patients 
have symptoms suspected PE, the first step is use of 
a clinical decision rules (CDR) such as the Wells score, 
the Pulmonary Embolism Rule-out Criteria (PERC), the 
5HYLVHG*HQHYDVFRUHWKH6LPSOL¿HG5HYLVHG*HQHYD
score and a D-dimer test
[3-5]
. 
CTA of the chest is the current gold standard for 
the diagnosis of PE. In the recently published American 
College of Radiology (ACR) Appropriateness Criteria
[6]
 
for Acute chest pain-suspected PE of intermediate 
probability with a negative D-dimer or low pretest pro-
bability, pulmonary magnetic resonance angiography 
(CE-MRA) is listed as 2 out of 10 for appropriateness 
(where 10/10 is the highest value for appropriateness), 
while multi-detector computed tomographic angiography 
(CTA) chest is listed at 5 out of 10 and a chest X-ray (CXR) 
is rated a 9 out 10. For acute chest pain-suspected 
PE of intermediate probability with a positive D-dimer 
or high pretest probability, the ACR appropriateness 
criteria rate CE-MRA as 6 out of 10, CTA chest is rated 
at 9 out of 10 and a CXR is rated at 9 out 10. It is im-
portant to remember that the use of D-dimer for inp-
atients is limited due to their many comorbities. Further 
imaging workup is unnecessary for the patients with a 
QHJDWLYH'GLPHUDQGDORZFOLQLFDOULVNSUR¿OHWRH[FOXGH
PE because the negative predictive value (NPV) does not 
change with the addition of an imaging test
[3,4]
.
EARLY WORK
The use of pulmonary MRA is playing an increasingly 
important role for the primary diagnosis of PE and other 
causes of acute chest pain
[2,7]
. Early studies in this area 
began in 1993 and demonstrated the efficacy for the 
non-contrast MRA for depiction of PE. However, there 
were limitations that hampered routine clinical use. 
In one of the early prospective studies (18 patients) 
of the efficacy of non-contrast enhanced MRA for the 
diagnosis of PE found the sensitivity of two-dimensional 
WLPHRIÀLJKWSXOPRQDU\EUHDWKKROG05$IRUGHWHFWLRQ
of acute PE was 85% and was much lower for chronic 
emboli at 42%
[8]
. This group also showed that the si-
ze of the emboli was important for CE-MRA detection 
(PE larger than 1 cm were found with more than 75% 
confidence)
[8]
. In another prospective study (20 pat-
ients) from 1993, two-dimensional time-of-flight MRA 
KDGDVHQVLWLYLW\RIDQGVSHFL¿FLW\RIIRU
the diagnosis of PE
[9]
. A major limitation of these studies 
ZDVWKHLUORZVHQVLWLYLW\DQGVSHFL¿FLW\IRUFKURQLFHP
boli, which were smaller and located eccentrically within 
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the pulmonary arteries (web-like). These limitations 
were due to low resolution, the artifacts from slow blood 
flow, and respiratory-motion artifacts (30-s breath-
hold). 
Since the 2000s, several studies have evaluated the 
performance of traditional contrast CE-MRA methods, 
namely breathhold, non-time resolved, 3D Cartesian 
encoded and T1-weighted spoiled gradient echo ac-
quisitions. These studies
[10-17]
 were often performed 
without parallel imaging and did not employ time-
resolved (e.g., 4 dimensional) k-space sampling which 
delineates the arterial and venous phases of the bolus 
passage thereby separating the pulmonary arteries 
from the pulmonary veins. In addition, 3D time-resolved 
CE-perfusion was not performed in conjunction with 
the routine CE-MRA in these works
[10-17]
. In comparison 
with the historic reference standard digital subtraction 
angiography (DSA), CE-MRA yielded a sensitivity and 
specificity for the detection of PE between 75% and 
100% and 95% and 100%, respectively; with good 
interobserver agreement (k values of 0.57-0.83)
[10-17]
. 
In contrast to traditional CE-MRA, a study using 
time-resolved CE-MRA directly compared diagnostic 
performance with DSA, CTA and/or nuclear medicine 
ventilation/perfusion imaging, and showed better dia-
gnostic performance than could be attained with DSA, 
CTA and/or nuclear medicine studies
[14]
. They showed a 
sensitivity and specificity of time-resolved CE-MRA of 
83% and 97% on a per-vascular zone basis and 92% 
DQGRQDSHUSDWLHQWEDVLV,QDGGLWLRQWKHHI¿FDF\
of time-resolved CE-MRA was higher than ventilation and 
perfusion scintigraphy (V/Q scan) on a per-patient basis. 
This study also showed that in comparison with CTA and 
VQ scans, time-resolved CE-MRA demonstrated equal 
to or higher sensitivity [92% vs 83% (CTA) and 67% (VQ 
VFDQ@DQGVSHFL¿FLW\> vs 94% (CTA) and 78% (VQ 
scan)] for the detection of PE
[14]
. 
Although time-resolved CE-MRA is useful for di-
agnosis of PE, dynamic first-pass CE-perfusion ma-
gnetic resonance imaging (MRI) is also helpful for 
disease severity assessment and outcome prediction 
in PE patients
[17]
. In this study, the acute pulmonary 
WKURPERHPEROLVP$37(LQGH[ZKLFKZDVGHILQHG
as the ratio between the volume of perfusion defects 
and the total lung volume determined by means of 
dynamic first-pass CE-perfusion MRI, showed accuracy 
for the prediction of patient outcome similar to that of 
the right ventricular/left ventricular (RV/LV) diameter 
ratio
[17],QDGGLWLRQWKHVSHFL¿FLW\DQGDFFXUDF\RIWKH
59/9GLDPHWHUUDWLRDQGWKH$37(LQGH[GHWHUPLQHG
E\PHDQVRIG\QDPLF¿UVWSDVV&(SHUIXVLRQ05,ZHUH
VLJQL¿FDQWO\KLJKHUWKDQWKRVHRI$37(LQGH[HVREWDLQHG
from embolic burdens and observed on CTACTA and 
time-resolved CE-MRA, although logistic regression 
DQDO\VLVGHPRQVWUDWHGWKDWHDFKLQGH[ZDVDVLJQL¿FDQW
predictor
[17]
. Although quantitatively analyzable software 
was not commercially available, this study showed the 
SRWHQWLDOXWLOLW\RITXDQWLWDWLYHO\DVVHVVHGG\QDPLF¿UVW
pass CE-perfusion MRI for patients with PE. Therefore, 
not only clinical researchers but also clinicians continue 
to urge companies in the field to provide appropriate 
MR systems, bolus injection protocols, MR sequences 
and software for clinical settings using this technique 
for suspected PE patients. Furthermore, there has been 
some work showing an advantage of MRI pulmonary 
perfusion assessment for patients suspected PE
[17,18]
. 
TEST EFFICACY
Prospective Investigation of Pulmonary Embolism 
Diagnosis ᶙ (PIOPED ᶙ) was a multicenter study 
designed to assess the efficacy of CE-MRA (without/
with MR venography) for diagnosing PE and venous 
thromboembolism (VTE)
[16]
. They found that CE-MRA 
was technically inadequate in 25% of their studies and 
WKDW&(05$KDGDVHQVLWLYLW\RIDQGDVSHFL¿FLW\
of 99%
[16]
. The two major reasons for this high rate of 
WHFKQLFDOLQDGHTXDF\ZHUHDVWULFWGH¿QLWLRQIRUFRPSOHWH
visualization of the subsegmental pulmonary arteries 
and the fact that some centers were just not as good 
as others in producing high quality studies
[19]
. They 
also found that using a combination of MRA and MR 
venography had a sensitivity of 92% and a specificity 
of 96%
[16]7KHLUUHVXOWVVKRZHGOLPLWHGHI¿FDF\RI&(
MRA for the diagnosis of PE. Based on their findings, 
the authors recommended that CE-MRA should only 
be considered at those centers that had a sufficient 
WHFKQLFDOH[SHUWLVHDQGLQWKRVHSDWLHQWVIRUZKHUHVW
andard tests were contraindicated
[16]
. 
The limitations of PIOPED ᶙ included a slightly lower 
resolution CE-MRA and a lack of consistent technical 
quality amongst the multiple centers
[16]
. This study me-
ntioned that CE-MRA could detect PE in a main or lobar 
pulmonary artery with a sensitivity of 79%. They also 
showed a sensitivity of 50% for segmental PE and 0% 
for detecting subsegmental PE (SSPE)
[16]
. In PIOPED ᶙ, 
WKHSURSRUWLRQRIWHFKQLFDOO\LQDGHTXDWHH[DPLQDWLRQV
varied between centers and ranged from 11% up to 
51%
[16]
. The reason why CE-MRA was technically in-
adequate was poor arterial opacification (67%), mo-
tion artifact (36%), wrap-around artifact (4%), and 
parallel imaging artifact (2%)
[16]
. Further retrospective 
analysis was by the PIOPED ᶙ investigators to identify 
WKHIDFWRUVRIWKH&(05$H[DPLQDWLRQWKDWZHUHDV
sociated with poor technical quality; they found that 
WKHWZRPRVWLPSRUWDQWHOHPHQWVLQÀXHQFLQJ05$LQ
terpretability were vascular opacification and motion 
artifact
[20]
. 
TREATMENT FOR SUBSEGMENTAL PE 
REMAINS A CONUNDRUM
7KHVLJQL¿FDQFHRIGHWHFWLQJVXEVHJPHQWDO3(663(
has been an ongoing debate for more than a decade
[21]
. 
An isolated SSPE could be a symptom of a thrombotic 
state, and may require treatment
[22]
. Recently Mehta 
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et al
[23]
 have shown that withholding anticoagulation 
in patients with a single SSPE and negative bilateral 
ORZHUH[WUHPLW\YHQRXVGXSOH[XOWUDVRXQGH[DPVZDV
a safe and effective strategy. However, systematic 
reviews demonstrated that no randomized controlled 
WULDOHYLGHQFHH[LVWVWRDOORZIRUDVDIHFRQFOXVLRQDV
to whether or not withholding anticoagulant therapy 
in isolated SSPE is safe
[24,25]
. Therefore, the detection 
of SSPE will remain an important issue. All interested 
parties should know that isolated SSPE are a problem 
for any diagnostic test, including the old gold (now br-
onze) reference method pulmonary angiography
[26]
 and 
the new gold standard CTA
[27]
. Nevertheless, long-term 
follow-up studies after normal pulmonary angiography
[28]
, 
normal perfusion scintigraphy
[29]
 and normal CTA
[30]
 have 
shown a low risk for recurrent disease after a single 
SSPE. 
MITIGATION OF MEDICAL RADIATION
The reasons to continue to work on improving non-cont-
rast and CE-MRA for diagnosing PE is the mitigation of 
medical radiation
[31-34]
. Ionizing radiation administered 
for medical imaging is of increasing clinical concern
[3,35,36]
 
and is a risk factor for the development of primary br-
east cancer
[37,38]
. The increased risk of breast cancer 
is associated with more imaging follow-up, higher cu-
PXODWLYHUDGLDWLRQGRVHVDQGH[SRVXUHDWD\RXQJHU
age
[38]
. CE-MRA is the only non-ionizing imaging mod-
ality with data supporting for the primary diagnosis of 
PE
[39]
. This modality is particularly useful for the follow 
up of previously diagnosed PE in younger individuals 
DQGWKHSHGLDWULFSRSXODWLRQWRGHWHUPLQHWKHHI¿FDF\RI
anticoagulation therapy, or the presence of new PE, as 
there is no incremental medical radiation. This strength 
of CE-MRA (no ionizing radiation) in younger patients 
KHOSVWRPLWLJDWHLWVORZHUHI¿FDF\IRUWKHGHWHFWLRQRI
SSPE.
TEST EFFECTIVENESS
At University of Wisconsin-Madison over 2000 pulm-
RQDU\&(05$H[DPLQDWLRQVIRUWKHSULPDU\GLDJQRVLV
of PE have been performed over the last ten years 
(2007-2017). The routine MRI protocol at UW-Madison 
is shown in Tables 1 and 2. We retrospectively reviewed 
the first 675 patients who underwent CE-MRA for the 
SULPDU\GLDJQRVLVRI3(WRGHWHUPLQHWKHVL[PRQWK
adverse event rate following the use of CE-MRA
[39]
. 
For all these patients, the same 13-17 s breath hold 
contrast enhanced CE-MRA method was used, and 
the details of the MRA imaging protocol has been pre-
viously described
[2]:HH[FOXGHGRI
patients for the following reasons: on anti-coagulation, 
SUHH[LVWLQJ,9&ILOWHURUDWULDOILEULOODWLRQ7ZRRI
(0.3%) were incomplete electronic medical record 
(EMR). Eventually, we included 617 (91.4%) patients to 
assess the effectiveness of CE-MRA
[39]
. Of the included 
cases, 500 (81%) were negative for PE, 17 (2.8%) 
were equivocal, 46 (7.5%) were positive for PE (Fig-
ure 1)
[39]
. The proportion of technically limited CE-MRA 
H[DPVDVGHWHUPLQHGE\WKHZRUG³OLPLWHG ´LQWKH¿QDO
report, was 8.8%. This result is far lower than the 25% 
technical failure rate reported in the PIOPED ᶙ[16]. This 
improvement in technical success likely reflects the 
maturation of CE-MRA methodology since the time of 
the PIOPED ᶙ scans nearly a decade ago (2006-2008). 
In addition, this improvement may be related to the fact 
that lack of visualization of the subsegmental pulmonary 
arteries was not a criterion for determining the presence 
RIDOLPLWHGH[DPLQDWLRQ2QO\WKUHHRISDW
LHQWVZLWKDQHJDWLYH&(05$H[DPH[SHULHQFHGD97(
ZLWKLQPRRIWKHLUH[DP7KXVXVLQJMXVWWKHUDWHRI
VTE, the NPV of CE-MRA was 99.4% in a data set that 
UHIOHFWVWKHUHDOZRUOGH[SHULHQFHRIWKLVWHVW[39]. This 
value is similar to the reported NPV for CTA (98.8%)
[40]
. 
At our single site, we have found that CE-MRA to be 
a safe and effective alternative to CTA for the primary 
diagnosis of PE.
PATIENT SELECTION
For accurate diagnosis, it is important to understand 
its appropriate use in the patient population. CE-
MRA for the primary diagnosis of PE is most effective 
when used in patients with the following criteria: (1) 
a low to intermediate pretest probability for venous 
thromboembolic disease; (2) patients with iodinated 
contrast allergies; (3) female subjects less than 35 
years of age that are potentially at slightly higher risk 
from medical radiation; and (4) for patients with renal 
LQVXIILFLHQF\H*)5WKHXVHRIIHUXPR[\WRODV
an MRA contrast agent may be considered. The con-
traindications for CE-MRA are as follows: (1) MRI inco-
mpatible implants
[41]
; (2) claustrophobia; (3) critically 
ill patients with a high pretest probability for PE; (4) 
inability to hold their breath for > 13 s; and (5) patients 
ZLWKJDGROLQLXPDQGIHUXPR[\WROFRQWUDVWDOOHUJLHV[42,43]. 
Please be aware of the fact that MRI is not safe for su-
spected PE patients that are unstable. This is because 
cardiopulmonary resuscitation can only be performed af-
ter the patient is out of the magnet room. 
OVERVIEW OF TECHNICAL METHODS 
FOR CE-MRA IN ACUTE PE
Imaging the lungs with CE-MRA is inherently chall-
enging as the method of blood pool enhancement is 
predominantly a T1 weighted contrast that is also con-
strained by a heavily T2* weighted background signal 
of the air within the lungs (0.5 ms and 2 ms T2*; at 
1.5T and 3T respectively)
[44]
. As such, delineation of 
the smaller vessels is difficult and this is made more 
challenging by the changes in susceptibility of the ves-
sels with contrast passage due to the T2* blooming 
effect. This effect can be mitigated by employing the 
following: (1) short echo time gradient echo sequenc-
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es
[45]
, for better resolution of the underlying lung and 
YHVVHOPRUSKRORJ\VFDQVDWH[SLUDWLRQDQG
parallel imaging
[46]
. Due to the above reasons, CE-MRA 
is primarily performed at 1.5T. However, using methods 
like ultra-short echo time radial sampling
[47]
 CE-MRA 
is also feasible at 3T. Incorporation of modest image 
acceleration factors using receiver array coils with auto 
calibrated parallel imaging and centric k-space encoding 
also helps in best capturing peak pulmonary arterial 
enhancement during bolus passage
[2,48]
.
NON-CONTRAST PULMONARY MRA
Multiple approaches are available for non-contrast imaging 
of the pulmonary arteries, pulmonary veins and perfusion 
of the lung parenchyma (Figure 2). The general protocol 
recommendations for imaging acute PE includes fast 
MRI imaging sequences to increase sensitivity and spe-
FL¿FLW\[15,49]. First, a steady state GRE sequence acquired 
in two or three planes during free breathing, may serve 
IRUHDUO\GHWHFWLRQRIODUJHFHQWUDOHPEROLZLWKLQWKH¿U
VW¿YHPLQXWHVRIWKHH[DPLQDWLRQZLWKDVHQVLWLYLW\
of 90% and a specificity approaching 100% (Figure 
3)
[15,50,51]
. Central embolism detected at this time can be 
directly referred to the intensive care unit for treatment, 
WKLVLVDVHI¿FLHQWDVGLDJQRVLVXVLQJ&7$[49]. In many 
cases, such as in pregnancy when the administration 
of Gadolinium based contrast agents (GABAs) is cri-
tical, using a non-contrast enhanced MRA can provide 
DUHOLDEOHH[FOXVLRQRIDPDVVLYHFHQWUDO3(7KHIXUWKHU
FRQWUDVWHQKDQFHGVWHSVRIWKHUHFRPPHQGHGH[D
PLQDWLRQSURWRFROZRXOGFRQWULEXWHWRFRQ¿UPWKLVUHVXOW
and increase sensitivity and specificity (Figure 3)
[2,49]
. 
The diagnostic accuracy of a non-contrast enhanced 
H[DPLQDWLRQFRXOGEHLPSURYHGE\DGGLWLRQDOQRQFR
ntrast enhanced perfusion imaging, based either on ar-
terial spin labeling or on Fourier decomposition (Figure 
2). Both have been shown to be sensitive for lung per-
IXVLRQGH¿FLWVUHODWHGWRDFXWH3(EXWDUHVWLOORQDQH[
perimental level
[52]
. 
The high contrast to noise of the blood pool with a 
steady state free precession sequence means that it 
can serve as a non-contrast enhanced MR angiogram
[53]
 
when performed in 3D breathhold. Recent developments 
with 3D UTE SSFP and zero echo time sequences
[54]
 also 
hold promise, however the lack of arterial and venous 
separation poses diagnostic limitations on this method 
when compared to state of the art CE MRA. Fourier 
decomposition (FD) MRI uses a continuously acquired 
two-dimensional steady-state free-precession (SSFP) 
or fast low angle shot (FLASH) acquisitions
[55,56]
. Since 
lung signal changes with inspiration depth (highest si-
JQDOZLWKORZHVWSXOPRQDU\DLUFRQWHQWLQH[SLUDWLRQ
DQGFDUGLDFPRWLRQORZHVWVLJQDOZLWKPD[LPXPEORRG
ÀRZLQV\VWROHERWKUHVXOWLQSHULRGLFFKDQJHVRIOXQJ
parenchymal signal that can be separated by means 
of Fourier decomposition
[57]
. Perfusion and ventilation-
weighted images are generated from the high frequency 
RVFLOODWLRQVUHODWHGWRWKHHIIHFWVRISXOVDWLOHEORRGÀRZ
and the low-frequency lung signal oscillation related 
to respiration without contrast
[55,58]
. Further promising 
new developments of this technique using self-gated 
non-contrast-enhanced functional lung imaging (SEN-
CEFUL) or phase-resolved functional lung (PREFUL) MRI 
have reported
[59,60]
. Principally, this technique has the 
potential to replace V/Q scans and has been already 
been validated against single-photon emission compu-
ted tomography (SPECT) perfusion and ventilation im-
aging
[61]
, and against hyperpolarized 3He and perfusion 
MRI
[62,63]
. In a single center study, perfusion weighted 
FD MRI showed encouraging results for the diagnosis 
of PE in the non-acute clinical setting
[64]
. Arterial spin 
labeling (ASL) uses the intrinsic contrast of magnetized, 
LQÀRZLQJEORRGLQWRWKHLPDJLQJSODQHRUYROXPHZLWKRXW
the need of contrast material injection
[52,65],QVFLHQWL¿F
applications, ASL has been used to study of the effects 
RILQKDOHGR[\JHQFRQFHQWUDWLRQDQGSK\VLFDOH[HUFLVH
on ventilation-perfusion heterogeneity of the lungs in 
healthy human subjects
[66-68]
. However, although being 
principally suitable for the detection of lung perfusion 
GH¿FLWVUHODWHGWRDFXWH3(QHLWKHUDUWHULDOVSLQODEHOLQJ
nor Fourier decomposition MRI have been clinically 
implemented for the assessment of acute PE, mainly 
because of the lower robustness against artifacts, lower 
spatial resolution and inferior signal to noise compared 
to contrast enhanced dynamic perfusion imaging
[52]
. 
Therefore, currently only steady-state GRE sequences 
are used when a non-contrast enhanced MRI of the pu-
lmonary vessels is required. 
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Table 1  Pulmonary contrast-enhanced magnetic resonance 
angiograph imaging protocol at UW-Madison after Nagle et al
[76]
Three-plane SSFSE localizers
Pre-contrast T1 weighted 3D SGRE
Pulmonary arterial phase T1-weighted 3D SGRE
Immediate post-contrast T1-weighted 3D SGRE
/RZÁLSDQJOHSRVWFRQWUDVW7ZHLJKWHG'6*5(
T1-weighted 2D axial or 3D SGRE with fat saturation
SGRE: Spoiled gradient recalled echo; MRA: Magnetic resonance ang-
iograph; SSFSE: Single-shot fast spin-echo.
Table 2  Pulmonary contrast-enhanced magnetic resonance 
angiograph pulse sequence parameters after Schiebler et al
[2]
Parameter Value
FOV WRÀWWKHSDWLHQWFP
Slice acquisition plane Sagittal
Resolution1 SI 0.7 × RL 0.7 × AP 1.0 mm3
TR/TE 2.9 ms/1.0 ms
Parallel imaging factor 3.6
Flip angle IRUQGSRVWFRQWUDVW´ORZÁLSDQJOHµ
scan)
Bandwidth ± 88 kHz/pixel
Time for Breath hold 15-21 s
1Interpolated resolution in all three planes. TR: Time to repetition; TE: 
Time to echo; FOV: Field of view.
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SAFETY OF GADOLINIUM BASED 
CONTRAST AGENTS
Currently GBCAs are used for CE-MRA, even in those 
patients with borderline renal function
[69]
. A recent meta-
analysis has shown that higher iconicity, protein binding 
and macrocyclic structures of GBCAs are associated with 
an increased number of acute allergic reactions
[42]
.
Recently work has shown gadolinium deposition in 
the brains, skin and bones of patients with normal renal 
function
[70-72]
. This can occur when linear or macrocyclic 
chelates GBCAs are used
[73]
. The association between 
the tissue deposition of gadolinium from GBCAs and 
any short or long-term clinical importance remains to be 
determined
[74]
. Due to concerns over brain Gadolinium 
deposition, macrocyclic agents such gadoterate megl-
umine and gadobutol are preferred
[75]
.
We currently recommend injection of 0.1 mmol/kg 
of GBCA diluted to a total volume of 30 mL with saline 
LQMHFWHGDWP/VDWHQGH[SLUDWLRQ[2,76]. The total 
length of time for the bolus administration of contrast 
material is important. Diluting the contrast with normal 
saline up to a volume of 30 mL allows administration 
of the entire length of the acquisition and thus helps to 
limit Maki artifacts (Figure 3). This artifact occurs when 
the scan acquisition starts before the bolus arrives, the 
effect is an edge-enhanced image and this can simulate 
PE
[77]
. 
RENAL FAILURE 
An option for patients with renal failure or GBCA allergy 
LVWKHRIIODEHOXVHRI)HUXPR[\WRODVD05$FRQWUDVW
agent
[78])HUXPR[\WROLVDQLQWUDYHQRXVO\DGPLQLVWHUHG
XOWUDVPDOOVXSHUSDUDPDJQHWLF LURQR[LGHDJHQWIRU
treatment of anemia in adult patients. The standard 
intravenous dose is 3.0 mg/kg. There is a Food and 
'UXJ$GPLQLVWUDWLRQ³EODFNER[´ZDUQLQJDJDLQVWWKH
rapid bolus administration of this agent, as it has been 
associated with hypotension and death. The rate of 
DQDSK\OD[LVLVORZDWWR[43]. Its T1 and T2 
shortening effects, long blood-pool residence time and 
clearance through the reticuloendothelial system makes 
this a versatile MRI contrast agent
[43,79]
. Moreover, Fer-
XPR[\WRODYRLGVDQ\ULVNRI1HSKURJHQLF6\VWHPLF)LE
rosis for patients with renal failure. 
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PREGNANCY 
PE is one of the causes of death in the pregnancy
[80,81]
. 
The diagnosis of PE in these patients is challenging 
because of the necessity of keeping medical radiation 
H[SRVXUHWRDPLQLPXP7KH$PHULFDQ7KRUDFLF6RFLHW\
and the Society of Thoracic Radiology have reached co-
nsensus in this clinical scenario
[82]
. They recommend 
ventilation-perfusion (V/Q) scintigraphy as a first line 
test to detect PE in pregnant patients with normal chest 
radiographs, with CTA reserved for those mothers wi-
th abnormal chest radiographs or indeterminate V/Q 
scans
[82]
. This remains an active area of research
[83]
. 
Non-contrast MRA using bright blood pulse sequences 
(bSSFP) and unenhanced Fourier decomposition lung 
perfusion are other options in this scenario that is non-
ionizing and without contrast for the mother and fetus 
(Figure 2)
[72,84]
. Unfortunately, CE-MRA using GBCAs 
is limited because these agents cross the placenta to 
the fetus and there are reports of rheumatological, 
inflammatory, and infiltrative skin conditions in those 
H[SRVHGQHRQDWHV[85]. Fortunately, there is another 
option for CE-MRA in this situation; the United States 
)RRGDQG'UXJ$GPLQLVWUDWLRQKDVDSSURYHG)HUXPR[\WRO
for use in pregnancy as a treatment for anemia, and 
we have used it (off-label) for CE-MRA in pregnant pa-
tients
[86]
. A recent Cochrane review assessed the value 
CTA, lung scintigraphy or MRA in pregnant patients with 
suspected PE
[87]1R05,H[DPLQDWLRQVPHWWKHLQFOXVLRQ 
criteria for the study. The authors concluded that both 
&7$DQGOXQJVFLQWLJUDSK\DUHDSSURSULDWHIRUH[FOXVLRQ
of PE in pregnancy, however it was unclear which test 
had the higher accuracy. They emphasized the need 
for direct comparisons and the need to include MRI in 
prospective trials in this clinical scenario
[87]
.
ARTIFACTS
Truncation artifact (Gibbs ringing) is showed as a dis-
tinct central signal intensity drop within the pulmonary 
vasculature in pulmonary contrast-enhanced MRA
[88]
. 
Gibbs ringing may be misdiagnosed as PE (Figure 4), 
SDUWLFXODUO\E\LQH[SHULHQFHG05$UHDGHUV7KHGL
fferentiation between Gibbs ringing and emboli is im-
portant. The signal intensity of this artifact is typically 
50% or higher than the enhanced surrounding vessel 
lumen
[88](UURUVDSSUR[LPDWLRQLQWKH)RXULHUWUDQVIRU
mation from k-space to image space causes this ar-
tifact (Figure 3). Routine Cartesian reconstructions of 
k-space into image space performs better when used for 
estimating gradual transitions in tissue signal intensity, 
not sharp ones
[88]
. There are cases where a Gibbs ar-
tifact is not distinguishable from a small central non-
occlusive PE
[88]
. In those cases, a confirmatory CTA 
H[DPLVUHTXLUHGIRUDQDFFXUDWHGLDJQRVLV7KH0DNL
artifact
[77]
 can also simulate a PE. This error in image 
interpretation is avoidable by using multiple contrast 
SKDVHVDQGH[WHQGLQJWKHEROXVVRWKDWFRQWUDVWLVDO
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ZD\VÀRZLQJLQWRWKHSXOPRQDU\DUWHULHVGXULQJWKH¿UVW
acquisition (Figure 3)
[76]
.
ANCILLARY FINDINGS
7KHDQFLOODU\ILQGLQJVREVHUYHGRQ&(05$H[DPVLQ
those patients without PE are similar to those of CTA 
(Figure 5)
[89,90]7KH¿HOGRIYLHZLVODUJHUDQGWKHVRIW
WLVVXHFRQWUDVWLVEHWWHURQ&(05$H[DPVWKDQ&7$
,QDUHFHQWVWXG\WKHLQFLGHQFHRIDFWLRQDEOH¿QGLQJV
UHTXLULQJIROORZXSIURP&(05$H[DPVZDV
(pleural effusion, pneumonia, malignancy, ascending 
aortic aneurysm, aortic dissection, pericardial effusion, 
heart failure, septic emboli, lung abscess, trauma, and 
VDUFRLGRVLV:KLOHWKHLQFLGHQFHRILQFLGHQWDO¿QGLQJV
WKRVH¿QGLQJVQRWUHTXLULQJIROORZXSZDVPLOG
dependent atelectasis, small pleural effusion, normal 
vascular variant, simple cysts in liver or kidney and pos-
t-surgical changes)
[89]
.
DIRECT AND INDIRECT FINDINGS OF PE
Just like multidetector computed tomographic angiog-
UDSK\0'&73(DUHGHWHFWHGDVDOXPHQDO¿OOLQJGHIHFW
in the pulmonary arteries on CE-MRA (Figure 1). Other 
direct findings include that arterial cutoff sign, double 
bronchus sign, and high T1 signal intensity clots. The 
LQGLUHFW¿QGLQJVLQFOXGHDWHOHFWDVLVSOHXUDOHIIXVLRQKL
gh signal adjacent draining pulmonary vein, the W-B-W 
(white-black-white) sign, perfusion defects, enhancing 
visceral pleural surfaces, and an enlarged pulmonary 
WUXQN2WKHU¿QGLQJVLQGLFDWLYHRIULJKWKHDUWVWUDLQDQG
elevated central venous pressure can help to estimate 
the degree of right heart dysfunction with larger clot 
burden
[7,91]
.
FREE BREATHING PE-MRA
In the PIOPED ᶙ study, the sensitivity of PE detected by 
MRA in subsegmental artery was 0%
[16]
. The emboli in 
VXEVHJPHQWDOYHVVHOVRQ05$DUHGLI¿FXOWWRGLVWLQJXLVK
from lung parenchyma or a nearby bronchus as this 
is a black-on-black perceptual event. Bannas et al
[47]
 
showed that free-breathing 3D radial ultra-short time to 
echo (UTE) imaging
[45]
 can detect PE in subsegmental 
vessels. The reason for this is the high SNR of lung 
parenchyma in the UTE image. Their method used a 
free-breathing 3D radial UTE technique, which is quite 
advantageous in the setting of dyspnea, a common 
presenting symptom of PE.
OVERDIAGNOSIS OF PE USING MDCT
MDCT is the gold standard for the primary diagnosis 
of PE
[6]
. The SSPE, which are not detected with V/Q 
scintigraphy or earlier generation single detector CT, 
are now routinely diagnosed with MDCT
[92]
. Le Gal et 
al
[92]
 in a review found that that MDCT found twice as 
many SSPE as the single detector CT scans. Sheh et 
al
[93]
 First introduced the concept of overdiagnosis 
of PE due to the change from V/Q scintigraphy to MD-
CT and an increased diagnosis of a much less fatal 
spectrum of PE. In contrast to the idea that SSPE is 
benign, other authors have shown that the presence 
of SSPE remains important for the likelihood of future 
venous thromboembolism (VTE)
[94-96]
. Current clinical 
practice guidelines suggest that anticoagulation therapy of 
these SSPE should be tailored to the individual patients 
ULVNVDQGEHQH¿WV[96]. The American College of Chest Ph-
ysicians 2016 guidelines now recommend withholding 
anticoagulation for SSPE in those patients with a low 
risk for recurrent thrombus and no concurrent deep ve-
in thrombosis
[97]
.
WEAKNESSES OF MRA
There are limitations for the use of MRA for the primary 
diagnosis of PE. First, this modality should not be used 
for unstable patients. Second, patients with allergies 
to gadolinium based contrast material should only be 
imaged if there is no access to MDCT or Ventilation Pe-
rfusion scanning, and only then after premedication 
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with steroids for 24 h and Benadryl. Third, small chil-
dren or adults who are unable to hold their breath, or 
hold still, for the 13-20 s MRA are poor candidates for 
WKLVH[DP)RXUWKUHDGHUVH[SHULHQFHGZLWKWKHLQW
erpretation of MRA for PE are needed to ensure that 
WKHFRUUHFWGLDJQRVLVLVUHDFKHGLQWKHVHH[DPV)LIWK
up to date MRI hardware (high performance gradients 
and multicoils) and software (rapid k-space sampling 
and accelerated image acquisition) are needed to allow 
IRUWKHDFTXLVLWLRQRI'05$H[DPVZLWKQHDUO\LVR
WURSLFYR[HOV7KHUHLVQRLVHDVVRFLDWHGZLWKWKHUDSLG
switching of the gradient coils that may bother some pa-
tients if there is not adequate hearing protection. 
The costs of this test will vary depending on each 
FRXQWU\¶VKHDOWKFDUHSODQ,QRXUH[SHULHQFHWKHFRVW
of this procedure is similar to MSCT for PE. There can be 
access challenges for the emergent use of CE-MRI for PE 
from the Emergency Department. With effort, we have 
IRXQGWKDWWKHWLPHIURPRUGHUWR¿QDOLQWHUSUHWDWLRQRI
WKHVHH[DPVFDQEHDURXQGRQHKRXU[76]([SHULHQFHG
VLWHVZLOOQRWKDYHGLI¿FXOW\VWDUWLQJD&(05$SURJUDP
for the primary diagnosis of PE, however we recognize 
that there are many medical centers that do not have 
access to these instruments and lack adequately tra-
ined medical/technical staff for the performance of 
WKHVHH[DPV,QWKLVORZWRLQWHUPHGLDWHULVNSDWLHQW
population, there are many patients that do not need 
imaging; this is why the careful application of CDRs is 
QHHGHGWRVFUHHQDOOSDWLHQWVSULRUWRRUGHULQJDQH[DP
for PE.
PERFORMANCE GAP: CE-MRA 
EFFECTIVENESS > EFFICACY
The most recent effectiveness data from UW-Madison 
showed a negative predictive value of 99% (95%CI: 
97%-100%) in 500 patients
[39]
. The reader can easily 
surmise that this effectiveness value (NPV-99%) is 
TXLWHGLIIHUHQWWKDQWKHHI¿FDF\YDOXHVHQVLWLYLW\
reported in PIOPED ᶙ[16]. How do we reconcile this 
difference? Perhaps this relative over-performance of 
CE-MRA, using outcomes data as a surrogate for ef-
fectiveness, vs WKHORZHUHIILFDF\FDQEHH[SODLQHGE\
the following possibilities: (1) Better technical CE-MRA 
H[DPVWKDQZHUHDYDLODEOHIRU3,23('ᶙ; (2) Readers 
H[SHULHQFHGZLWKWKHDUWLIDFWVRIWKLVH[DPDQG
Small PE in younger and healthy patients, that may 
be missed on CE-MRA or NM V/Q scanning are not im-
portant for survival or subsequent VTE. One reason for 
this may be that these isolated SSPEs may indeed 
be scrubbed from the pulmonary arterial vasculature 
by the patients endogenous thrombolytic activity. An-
other possible reason is that there is a great deal of 
cardiopulmonary reserve and that sacrifice of a few 
subsegmental pulmonary arteries is not significant in 
the normal population. Please note that the situation 
of repeated SSPE may lead to chronic thromboembolic 
pulmonary hypertension
[98]
.
Recently Cronin and Dwamena
[99]
 have used the 
PIOPED ᶘ data to calculate likelihood ratios (LR) for 
PE in this cohort based on the pretest probability from 
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CDR (e.g., Wells score, Geneva score and Pisa score). 
The use of LR is important in this age of outcomes dri-
YHQUHVHDUFKDVWKHVHUHÀHFWWKHFOLQLFDOXWLOLW\RIDQ\
given testing method. The numerator of the positive LR 
(+LR) is the sensitivity of the test for that disease. 
7KHGHQRPLQDWRULVVSHFL¿FLW\RIWKHWHVWIRUWKDWGLV
ease
[99]
. Their analysis showed that the use of CE-MRA 
for the diagnosis of PE had a higher LR+ than CTA
[99]
.
/5 6HQVLWLYLW\VSHFL¿FLW\
CONCLUSION
Currently computed tomographic angiography is the st-
udy of choice for the diagnosis of PE. We have reviewed 
RXUH[SHULHQFHXVLQJSXOPRQDU\&(05$DVD¿UVWOLQH
diagnostic test for patients suspected of having PE. We 
KDYHIRXQGHTXLYDOHQWVL[PRQWKRXWFRPHVWRFRPSXWHG
tomographic angiography when using this test. We 
recommend using strict patient selection criteria for 
improving the likelihood for the technical success of th-
is test. First, a low to intermediate pretest probability 
for venous thromboembolic disease by the formalized is 
used of CDR (Wells criteria, PERC or the Geneva score); 
Second, patients with iodinated contrast allergies can 
benefit from using this test; Third, female subjects 
less than 35 years of age to mitigate medical radiation 
H[SRVXUHWRWKHEUHDVW)RXUWKHPSOR\LQJIHUXPR[\WRO
as the MRA contrast agent in renal failure patients; 
Finally, yet importantly, ensuring that the patient is st-
able and can hold their breath for the 13-17 s CE-MRA. 
There is no overdiagnosis of PE when CE-MRA or NM V/Q 
scanning is used. In other words, these less sensitive 
tests may suffice for the primary diagnosis of PE. We 
are supportive of funding for randomized clinical trials to 
HYDOXDWHZKHWKHURUQRWWKHFOLQLFDORXWFRPHVVLJQL¿FDQWO\
vary between CTA and CE-MRA for the primary diagnosis 
of PE, as this remains an unmet need.
ACKNOWLEDGEMENTS
The authors wish to acknowledge the research support 
of the Department of Radiology, UW-Madison and GE 
Healthcare.
REFERENCES 
1  Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA 
Cancer J Clin 2012; 62: 10-29 [PMID: 22237781 DOI: 10.3322/
caac.20138]
2  Schiebler ML, Nagle SK, François CJ, Repplinger MD, Hamedani 
AG, Vigen KK, Yarlagadda R, Grist TM, Reeder SB. Effectiveness 
of MR angiography for the primary diagnosis of acute pulmonary 
embolism: clinical outcomes at 3 months and 1 year. J Magn Reson 
Imaging 2013; 38: 914-925 [PMID: 23553735 DOI: 10.1002/
jmri.24057]
3  Levin D, Seo JB, Kiely DG, Hatabu H, Gefter W, van Beek 
EJ, Schiebler ML; 2013 International Workshop for Pulmonary 
Functional Imaging (IWPFI). Triage for suspected acute Pul-
monary Embolism: Think before opening Pandoras Box. Eur J 
Radiol 2015; 84: 1202-1211 [PMID: 25864020 DOI: 10.1016/
j.ejrad.2015.03.023]
4  Harringa JB, Bracken RL, Nagle SK, Schiebler ML, Pulia MS, 
Svenson JE, Repplinger MD. Negative D-dimer testing excludes 
pulmonary embolism in non-high risk patients in the emergency 
department. Emerg Radiol 2017; 24: 273-280 [PMID: 28116533 
DOI: 10.1007/s10140-017-1478-6]
5  Sikkens JJ, Beekman DG, Thijs A, Bossuyt PM, Smulders YM. 
How Much Overtesting Is Needed to Safely Exclude a Diagnosis? 
A Different Perspective on Triage Testing Using Bayes Theorem. 
PLoS One 2016; 11: e0150891 [PMID: 26939066 DOI: 10.1371/
journal.pone.0150891]
6  Expert Panels on Cardiac and Thoracic Imaging. Kirsch J, 
Brown RKJ, Henry TS, Javidan-Nejad C, Jokerst C, Julsrud 
PR, Kanne JP, Kramer CM, Leipsic JA, Panchal KK, Ravenel 
JG, Shah AB, Mohammed TL, Woodard PK, Abbara S. ACR 
Appropriateness Criteria® Acute Chest Pain-Suspected Pulmonary 
Embolism. J Am Coll Radiol 2017; 14: S2-S12 [PMID: 28473076 
DOI: 10.1016/j.jacr.2017.02.027]
7  François CJ, Hartung MP, Reeder SB, Nagle SK, Schiebler ML. 
MRI for acute chest pain: current state of the art. J Magn Reson 
Imaging 2013; 37: 1290-1300 [PMID: 23589367 DOI: 10.1002/
jmri.24173]
8  Schiebler ML, Holland GA, Hatabu H, Listerud J, Foo T, Palevsky 
H, Edmunds H, Gefter WB. Suspected pulmonary embolism: 
prospective evaluation with pulmonary MR angiography. Rad-
iology 1993; 189: 125-131 [PMID: 8372181 DOI: 10.1148/rad-
iology.189.1.8372181]
9  Grist TM, Sostman HD, MacFall JR, Foo TK, Spritzer CE, Witty 
L, Newman GE, Debatin JF, Tapson V, Saltzman HA. Pulmonary 
angiography with MR imaging: preliminary clinical experience. 
Radiology 1993; 189: 523-530 [PMID: 8210385 DOI: 10.1148/
radiology.189.2.8210385]
10  Meaney JF, Weg JG, Chenevert TL, Stafford-Johnson D, Hamilton 
BH, Prince MR. Diagnosis of pulmonary embolism with magnetic 
resonance angiography. N Engl J Med 1997; 336: 1422-1427 
[PMID: 9145679 DOI: 10.1056/NEJM199705153362004]
11  Gupta A, Frazer CK, Ferguson JM, Kumar AB, Davis SJ, Fallon 
MJ, Morris IT, Drury PJ, Cala LA. Acute pulmonary embolism: 
diagnosis with MR angiography. Radiology 1999; 210: 353-359 
[PMID: 10207414 DOI: 10.1148/radiology.210.2.r99fe53353]
12  Oudkerk M, van Beek EJ, Wielopolski P, van Ooijen PM, Brou-
wers-Kuyper EM, Bongaerts AH, Berghout A. Comparison of 
contrast-enhanced magnetic resonance angiography and conv-
entional pulmonary angiography for the diagnosis of pulmonary 
embolism: a prospective study. Lancet 2002; 359: 1643-1647 
[PMID: 12020524 DOI: 10.1016/S0140-6736(02)08596-3]
13  Ohno Y, Kawamitsu H, Higashino T, Takenaka D, Watanabe H, 
van Cauteren M, Fujii M, Hatabu H, Sugimura K. Time-resolved 
contrast-enhanced pulmonary MR angiography using sensitivity 
encoding (SENSE). J Magn Reson Imaging 2003; 17: 330-336 
[PMID: 12594723 DOI: 10.1002/jmri.10261]
14  Ohno Y, Higashino T, Takenaka D, Sugimoto K, Yoshikawa T, 
Kawai H, Fujii M, Hatabu H, Sugimura K. MR angiography with 
sensitivity encoding (SENSE) for suspected pulmonary embolism: 
comparison with MDCT and ventilation-perfusion scintigraphy. 
AJR Am J Roentgenol 2004; 183: 91-98 [PMID: 15208117 DOI: 
10.2214/ajr.183.1.1830091]
15  Kluge A, Luboldt W, Bachmann G. Acute pulmonary embolism 
to the subsegmental level: diagnostic accuracy of three MRI tech-
niques compared with 16-MDCT. AJR Am J Roentgenol 2006; 187: 
W7-14 [PMID: 16794142 DOI: 10.2214/AJR.04.1814]
16  Stein PD, Chenevert TL, Fowler SE, Goodman LR, Gottschalk 
A, Hales CA, Hull RD, Jablonski KA, Leeper KV Jr, Naidich DP, 
Sak DJ, Sostman HD, Tapson VF, Weg JG, Woodard PK; PIOPED 
III (Prospective Investigation of Pulmonary Embolism Diagnosis 
III) Investigators. Gadolinium-enhanced magnetic resonance 
angiography for pulmonary embolism: a multicenter prospective 
study (PIOPED III). Ann Intern Med 2010; 152: 434-443, 
W142-W143 [PMID: 20368649 DOI: 10.7326/0003-4819-152-7-2
01004060-00008]
17  Ohno Y, Koyama H, Matsumoto K, Onishi Y, Nogami M, Take-
June 28, 2018|Volume 10|Issue 6|
Tsuchiya N et al . CE-MRA for the primary diagnosis of pulmonary embolism
62WJR|www.wjgnet.com
naka D, Yoshikawa T, Matsumoto S, Sugimura K. Dynamic MR 
perfusion imaging: capability for quantitative assessment of disease 
extent and prediction of outcome for patients with acute pulmonary 
thromboembolism. J Magn Reson Imaging 2010; 31: 1081-1090 
[PMID: 20432342 DOI: 10.1002/jmri.22146]
18  Kalb B, Sharma P, Tigges S, Ray GL, Kitajima HD, Costello 
JR, Chen Z, Martin DR. MR imaging of pulmonary embolism: 
diagnostic accuracy of contrast-enhanced 3D MR pulmonary 
DQJLRJUDSK\FRQWUDVWHQKDQFHGORZÀLSDQJOH'*5(DQGQRQH
nhanced free-induction FISP sequences. Radiology 2012; 263: 
271-278 [PMID: 22438448 DOI: 10.1148/radiol.12110224]
19  Sostman HD, Jablonski KA, Woodard PK, Stein PD, Naidich DP, 
Chenevert TL, Weg JG, Hales CA, Hull RD, Goodman LR, Tapson 
VF. Factors in the technical quality of gadolinium enhanced mag-
netic resonance angiography for pulmonary embolism in PIOPED 
III. Int J Cardiovasc Imaging 2012; 28: 303-312 [PMID: 21347594 
DOI: 10.1007/s10554-011-9820-7]
20  Woodard PK, Chenevert TL, Sostman HD, Jablonski KA, Stein 
PD, Goodman LR, Londy FJ, Narra V, Hales CA, Hull RD, Tapson 
VF, Weg JG. Signal quality of single dose gadobenate dimeglumine 
pulmonary MRA examinations exceeds quality of MRA performed 
with double dose gadopentetate dimeglumine. Int J Cardiovasc 
Imaging 2012; 28: 295-301 [PMID: 21337023 DOI: 10.1007/
s10554-011-9821-6]
21  Goodman LR. Small pulmonary emboli: what do we know? 
Radiology 2005; 234: 654-658 [PMID: 15734923 DOI: 10.1148/
radiol.2343041326]
22  Yoo HH, Queluz TH, El Dib R. Anticoagulant treatment for subs-
egmental pulmonary embolism. Cochrane Database Syst Rev 
2016; (1): CD010222 [PMID: 26756331 DOI: 10.1002/14651858.
CD010222.pub3]
23  Mehta D, Barnett M, Zhou L, Woulfe T, Rolfe-Vyson V, Rowland 
V, Simpson D, Merriman E. Management and outcomes of single 
subsegmental pulmonary embolus: a retrospective audit at North 
Shore Hospital, New Zealand. Intern Med J 2014; 44: 872-876 
[PMID: 24942202 DOI: 10.1111/imj.12507]
24  Carrier M, Righini M, Wells PS, Perrier A, Anderson DR, Rodger 
MA, Pleasance S, Le Gal G. Subsegmental pulmonary embolism 
diagnosed by computed tomography: incidence and clinical imp-
lications. A systematic review and meta-analysis of the management 
outcome studies. J Thromb Haemost 2010; 8: 1716-1722 [PMID: 
20546118 DOI: 10.1111/j.1538-7836.2010.03938.x]
25  Yoo HH, Queluz TH, El Dib R. Anticoagulant treatment for subs-
egmental pulmonary embolism. Cochrane Database Syst Rev 
2014; (4): CD010222 [PMID: 24771493 DOI: 10.1002/14651858.
CD010222.pub2]
26  van Beek EJ, Bakker AJ, Reekers JA. Pulmonary embolism: 
interobserver agreement in the interpretation of conventional angi-
ographic and DSA images in patients with nondiagnostic lung scan 
results. Radiology 1996; 198: 721-724 [PMID: 8628860 DOI: 
10.1148/radiology.198.3.8628860]
27  Anderson DR, Kahn SR, Rodger MA, Kovacs MJ, Morris T, 
Hirsch A, Lang E, Stiell I, Kovacs G, Dreyer J, Dennie C, Cartier 
Y, Barnes D, Burton E, Pleasance S, Skedgel C, ORouke K, Wells 
PS. Computed tomographic pulmonary angiography vs ventilation-
perfusion lung scanning in patients with suspected pulmonary 
embolism: a randomized controlled trial. JAMA 2007; 298: 
2743-2753 [PMID: 18165667 DOI: 10.1001/jama.298.23.2743]
28  van Beek EJ, Brouwerst EM, Song B, Stein PD, Oudkerk M. 
Clinical validity of a normal pulmonary angiogram in patients with 
suspected pulmonary embolism-a critical review. Clin Radiol 2001; 
56: 838-842 [PMID: 11895301 DOI: 10.1053/crad.2001.0778]
29  van Beek EJ, Kuyer PM, Schenk BE, Brandjes DP, ten Cate JW, 
Büller HR. A normal perfusion lung scan in patients with clinically 
suspected pulmonary embolism. Frequency and clinical validity. 
Chest 1995; 108: 170-173 [PMID: 7606954 DOI: 10.1378/ch-
est.108.1.170]
30  van der Hulle T, van Es N, den Exter PL, van Es J, Mos ICM, 
Douma RA, Kruip MJHA, Hovens MMC, Ten Wolde M, Nijkeuter 
M, Ten Cate H, Kamphuisen PW, Büller HR, Huisman MV, Klok 
FA. Is a normal computed tomography pulmonary angiography 
safe to rule out acute pulmonary embolism in patients with a 
likely clinical probability? A patient-level meta-analysis. Thromb 
Haemost 2017; 117: 1622-1629 [PMID: 28569924 DOI: 10.1160/
TH17-02-0076]
31  Brenner DJ. What we know and what we dont know about cancer 
risks associated with radiation doses from radiological imaging. 
Br J Radiol 2014; 87: 20130629 [PMID: 24198200 DOI: 10.1259/
bjr.20130629]
32  Shuryak I, Brenner DJ. Mechanistic analysis of the contributions 
of DNA and protein damage to radiation-induced cell death. Radiat 
Res 2012; 178: 17-24 [PMID: 22663149 DOI: 10.1667/RR2877.1]
33  Brenner DJ. Radiation and chest CT scans: are there problems? 
What should we do? Chest 2012; 142: 549-550 [PMID: 22948569 
DOI: 10.1378/chest.12-0490]
34  Brenner DJ. We can do better than effective dose for estimating or 
comparing low-dose radiation risks. Ann ICRP 2012; 41: 124-128 
[PMID: 23089011 DOI: 10.1016/j.icrp.2012.07.001]
35  Journy NMY, Dreuil S, Boddaert N, Chateil JF, Defez D, Ducou-
le-Pointe H, Garcier JM, Guersen J, Habib Geryes B, Jahnen A, 
Lee C, Payen-de-la-Garanderie J, Pracros JP, Sirinelli D, Thierry-
Chef I, Bernier MO. Individual radiation exposure from computed 
tomography: a survey of paediatric practice in French university 
hospitals, 2010-2013. Eur Radiol 2018; 28: 630-641 [PMID: 
28836026 DOI: 10.1007/s00330-017-5001-y]
36  Journy NM, Lee C, Harbron RW, McHugh K, Pearce MS, Ber-
rington de González A. Projected cancer risks potentially related 
to past, current, and future practices in paediatric CT in the United 
Kingdom, 1990-2020. Br J Cancer 2017; 116: 109-116 [PMID: 
27824812 DOI: 10.1038/bjc.2016.351]
37  Pijpe A, Andrieu N, Easton DF, Kesminiene A, Cardis E, Noguès C, 
Gauthier-Villars M, Lasset C, Fricker JP, Peock S, Frost D, Evans 
DG, Eeles RA, Paterson J, Manders P, van Asperen CJ, Ausems 
MG, Meijers-Heijboer H, Thierry-Chef I, Hauptmann M, Goldgar 
D, Rookus MA, van Leeuwen FE; GENEPSO; EMBRACE; 
HEBON. Exposure to diagnostic radiation and risk of breast cancer 
among carriers of BRCA1/2 mutations: retrospective cohort study 
(GENE-RAD-RISK). BMJ 2012; 345: e5660 [PMID: 22956590 
DOI: 10.1136/bmj.e5660]
38  Drooger JC, Hooning MJ, Seynaeve CM, Baaijens MH, Obdeijn 
IM, Sleijfer S, Jager A. Diagnostic and therapeutic ionizing 
UDGLDWLRQDQGWKHULVNRID¿UVWDQGVHFRQGSULPDU\EUHDVWFDQFHU
with special attention for BRCA1 and BRCA2 mutation carriers: 
a critical review of the literature. Cancer Treat Rev 2015; 41: 
187-196 [PMID: 25533736 DOI: 10.1016/j.ctrv.2014.12.002]
39  Schiebler M, Francois C, Repplinger M, Hamedani A, Lindholm 
C, Vigen K, Munoz del Rio A, Grist T, Reeder S, Nagle S. Eff-
ectiveness of Pulmonary Contrast Enhanced Magnetic Resonance 
Angiography for the primary workup of pulmonary embolism. 
ISMRM 24th Annual Meeting and Exhibition; 2016 May 7-13; 
Singapore; Oral abstract presentation, No. 1074
40  Mos IC, Klok FA, Kroft LJ, DE Roos A, Dekkers OM, Huisman 
MV. Safety of ruling out acute pulmonary embolism by normal 
computed tomography pulmonary angiography in patients with 
an indication for computed tomography: systematic review and 
meta-analysis. J Thromb Haemost 2009; 7: 1491-1498 [PMID: 
19552684 DOI: 10.1111/j.1538-7836.2009.03518.x]
41  Shellock FG. Magnetic resonance safety update 2002: implants 
and devices. J Magn Reson Imaging 2002; 16: 485-496 [PMID: 
12412025 DOI: 10.1002/jmri.10196]
42  Behzadi AH, Zhao Y, Farooq Z, Prince MR. Immediate Allergic 
Reactions to Gadolinium-based Contrast Agents: A Systematic 
Review and Meta-Analysis. Radiology 2018; 286: 731 [PMID: 
29356629 DOI: 10.1148/radiol.2017174037]
43  Vasanawala SS, Nguyen KL, Hope MD, Bridges MD, Hope 
TA, Reeder SB, Bashir MR. Safety and technique of ferumoxytol 
administration for MRI. Magn Reson Med 2016; 75: 2107-2111 
[PMID: 26890830 DOI: 10.1002/mrm.26151]
44  Alsop DC, Hatabu H, Bonnet M, Listerud J, Gefter W. Multi-
slice, breathhold imaging of the lung with submillisecond echo 
June 28, 2018|Volume 10|Issue 6|
Tsuchiya N et al . CE-MRA for the primary diagnosis of pulmonary embolism
63WJR|www.wjgnet.com
times. Magn Reson Med 1995; 33: 678-682 [PMID: 7596272 DOI: 
10.1002/mrm.1910330513]
45  Johnson KM, Fain SB, Schiebler ML, Nagle S. Optimized 3D 
ultrashort echo time pulmonary MRI. Magn Reson Med 2013; 70: 
1241-1250 [PMID: 23213020 DOI: 10.1002/mrm.24570]
46  Griswold MA, Blaimer M, Breuer F, Heidemann RM, Mueller 
M, Jakob PM. Parallel magnetic resonance imaging using the 
GRAPPA operator formalism. Magn Reson Med 2005; 54: 
1553-1556 [PMID: 16254956 DOI: 10.1002/mrm.20722]
47  Bannas P, Bell LC, Johnson KM, Schiebler ML, François CJ, 
Motosugi U, Consigny D, Reeder SB, Nagle SK. Pulmonary 
Embolism Detection with Three-dimensional Ultrashort Echo Time 
MR Imaging: Experimental Study in Canines. Radiology 2016; 
278: 413-421 [PMID: 26422185 DOI: 10.1148/radiol.2015150606]
48  Brau AC, Beatty PJ, Skare S, Bammer R. Comparison of reco-
nstruction accuracy and efficiency among autocalibrating data-
driven parallel imaging methods. Magn Reson Med 2008; 59: 
382-395 [PMID: 18228603 DOI: 10.1002/mrm.21481]
49  Biederer J, Beer M, Hirsch W, Wild J, Fabel M, Puderbach M, Van 
Beek EJ. MRI of the lung (2/3). Why  when  how? Insights 
Imaging 2012; 3: 355-371 [PMID: 22695944 DOI: 10.1007/
s13244-011-0146-8]
50  Kluge A, Gerriets T, Stolz E, Dill T, Mueller KD, Mueller C, 
Bachmann G. Pulmonary perfusion in acute pulmonary emb-
olism: agreement of MRI and SPECT for lobar, segmental and 
subsegmental perfusion defects. Acta Radiol 2006; 47: 933-940 
[PMID: 17077044 DOI: 10.1080/02841850600885377]
51  Kluge A, Gerriets T, Müller C, Ekinci O, Neumann T, Dill T, 
Bachmann G. [Thoracic real-time MRI: experience from 2200 
H[DPLQDWLRQVLQDFXWHDQGLOOGH¿QHGWKRUDFLFGLVHDVHV@Rofo 2005; 
177: 1513-1521 [PMID: 16302132 DOI: 10.1055/s-2005-858688]
52  Biederer J, Heussel CP, Puderbach M, Wielpuetz MO. Functional 
magnetic resonance imaging of the lung. Semin Respir Crit 
Care Med 2014; 35: 74-82 [PMID: 24481761 DOI: 10.1055/
s-0033-1363453]
53  Edelman RR, Silvers RI, Thakrar KH, Metzl MD, Nazari J, Giri 
S, Koktzoglou I. Nonenhanced MR angiography of the pulmonary 
arteries using single-shot radial quiescent-interval slice-selective 
(QISS): a technical feasibility study. J Cardiovasc Magn Reson 
2017; 19: 48 [PMID: 28662717 DOI: 10.1186/s12968-017-0365-3]
54  Gibiino F, Sacolick L, Menini A, Landini L, Wiesinger F. Free-
breathing, zero-TE MR lung imaging. MAGMA 2015; 28: 207-215 
[PMID: 25200814 DOI: 10.1007/s10334-014-0459-y]
55  Bauman G, Puderbach M, Deimling M, Jellus V, Chefdhotel C, 
Dinkel J, Hintze C, Kauczor HU, Schad LR. Non-contrast-enhanced 
perfusion and ventilation assessment of the human lung by means 
of fourier decomposition in proton MRI. Magn Reson Med 2009; 
62: 656-664 [PMID: 19585597 DOI: 10.1002/mrm.22031]
56  Voskrebenzev A, Gutberlet M, Becker L, Wacker F, Vogel-
Claussen J. Reproducibility of fractional ventilation derived by 
Fourier decomposition after adjusting for tidal volume with and 
without an MRI compatible spirometer. Magn Reson Med 2016; 
76: 1542-1550 [PMID: 26745750 DOI: 10.1002/mrm.26047]
57  Suga K, Ogasawara N, Okada M, Tsukuda T, Matsunaga N, 
Miyazaki M. Lung perfusion impairments in pulmonary embolic 
and airway obstruction with noncontrast MR imaging. J Appl 
Physiol (1985) 2002; 92: 2439-2451 [PMID: 12015358 DOI: 
10.1152/japplphysiol.00900.2001]
58  Bauman G, Johnson KM, Bell LC, Velikina JV, Samsonov AA, 
Nagle SK, Fain SB. Three-dimensional pulmonary perfusion MRI 
with radial ultrashort echo time and spatial-temporal constrained 
reconstruction. Magn Reson Med 2015; 73: 555-564 [PMID: 
24604452 DOI: 10.1002/mrm.25158]
59  Fischer A, Weick S, Ritter CO, Beer M, Wirth C, Hebestreit H, 
Jakob PM, Hahn D, Bley T, Köstler H. SElf-gated Non-Contrast-
Enhanced FUnctional Lung imaging (SENCEFUL) using a quasi-
random fast low-angle shot (FLASH) sequence and proton MRI. 
NMR Biomed 2014; 27: 907-917 [PMID: 24820869 DOI: 10.1002/
nbm.3134]
60  Voskrebenzev A, Gutberlet M, Klime F, Kaireit TF, Schönfeld C, 
Rotärmel A, Wacker F, Vogel-Claussen J. Feasibility of quantitative 
regional ventilation and perfusion mapping with phase-resolved 
functional lung (PREFUL) MRI in healthy volunteers and COPD, 
CTEPH, and CF patients. Magn Reson Med 2018; 79: 2306-2314 
[PMID: 28856715 DOI: 10.1002/mrm.26893]
61  Bauman G, Lützen U, Ullrich M, Gaass T, Dinkel J, Elke G, 
Meybohm P, Frerichs I, Hoffmann B, Borggrefe J, Knuth HC, 
Schupp J, Prüm H, Eichinger M, Puderbach M, Biederer J, Hintze 
C. Pulmonary functional imaging: qualitative comparison of 
Fourier decomposition MR imaging with SPECT/CT in porcine 
lung. Radiology 2011; 260: 551-559 [PMID: 21586678 DOI: 
10.1148/radiol.11102313]
62  Bauman G, Scholz A, Rivoire J, Terekhov M, Friedrich J, de 
Oliveira A, Semmler W, Schreiber LM, Puderbach M. Lung 
ventilation- and perfusion-weighted Fourier decomposition 
magnetic resonance imaging: in vivo validation with hyperpolarized 
3He and dynamic contrast-enhanced MRI. Magn Reson Med 2013; 
69: 229-237 [PMID: 22392633 DOI: 10.1002/mrm.24236]
63  Bauman G, Bieri O. Matrix pencil decomposition of time-resolved 
proton MRI for robust and improved assessment of pulmonary 
ventilation and perfusion. Magn Reson Med 2017; 77: 336-342 
[PMID: 26757102 DOI: 10.1002/mrm.26096]
64  Schönfeld C, Cebotari S, Voskrebenzev A, Gutberlet M, Hin-
richs J, Renne J, Hoeper MM, Olsson KM, Welte T, Wacker F, 
Vogel-Claussen J. Performance of perfusion-weighted Fourier 
decomposition MRI for detection of chronic pulmonary emboli. 
J Magn Reson Imaging 2015; 42: 72-79 [PMID: 25227559 DOI: 
10.1002/jmri.24764]
65  Keilholz SD, Mai VM, Berr SS, Fujiwara N, Hagspiel KD. Comp-
DULVRQRI¿UVWSDVV*G'27$DQG)$,5(505SHUIXVLRQLPDJLQJ
in a rabbit model of pulmonary embolism. J Magn Reson Imaging 
2002; 16: 168-171 [PMID: 12203764 DOI: 10.1002/jmri.10138]
66  Arai TJ, Henderson AC, Dubowitz DJ, Levin DL, Friedman 
PJ, Buxton RB, Prisk GK, Hopkins SR. Hypoxic pulmonary 
YDVRFRQVWULFWLRQGRHVQRWFRQWULEXWHWRSXOPRQDU\EORRGÀRZKHWHU
ogeneity in normoxia in normal supine humans. J Appl Physiol 
(1985) 2009; 106: 1057-1064 [PMID: 19057006 DOI: 10.1152/
japplphysiol.90759.2008]
67  Burnham KJ, Arai TJ, Dubowitz DJ, Henderson AC, Holverda 
S, Buxton RB, Prisk GK, Hopkins SR. Pulmonary perfusion 
heterogeneity is increased by sustained, heavy exercise in humans. 
J Appl Physiol (1985) 2009; 107: 1559-1568 [PMID: 19745192 
DOI: 10.1152/japplphysiol.00491.2009]
68  Mai VM, Knight-Scott J, Berr SS. Improved visualization of the 
human lung in 1H MRI using multiple inversion recovery for 
simultaneous suppression of signal contributions from fat and 
muscle. Magn Reson Med 1999; 41: 866-870 [PMID: 10332866 
DOI: 10.1002/(SICI)1522-2594(199905)41:5<866::AID-MR-
M2>3.0.CO;2-D]
69  Soulez G, Bloomgarden DC, Rofsky NM, Smith MP, Abujudeh 
HH, Morgan DE, Lichtenstein RJ, Schiebler ML, Wippold FJ 
2nd, Russo C, Kuhn MJ, Mennitt KW, Maki JH, Stolpen A, Liou 
J, Semelka RC, Kirchin MA, Shen N, Pirovano G, Spinazzi A. 
Prospective Cohort Study of Nephrogenic Systemic Fibrosis in 
Patients With Stage 3-5 Chronic Kidney Disease Undergoing MRI 
With Injected Gadobenate Dimeglumine or Gadoteridol. AJR Am J 
Roentgenol 2015; 205: 469-478 [PMID: 26295633 DOI: 10.2214/
AJR.14.14268]
70  Prybylski JP, Semelka RC, Jay M. The stability of gadolinium-
based contrast agents in human serum: A reanalysis of literature data 
and association with clinical outcomes. Magn Reson Imaging 2017; 
38: 145-151 [PMID: 28089499 DOI: 10.1016/j.mri.2017.01.006]
71  Huckle JE, Altun E, Jay M, Semelka RC. Gadolinium Deposition 
in Humans: When Did We Learn That Gadolinium Was Deposited 
In Vivo? Invest Radiol 2016; 51: 236-240 [PMID: 26588463 DOI: 
10.1097/RLI.0000000000000228]
72  Herédia V, Altun E, Ramalho M, de Campos R, Azevedo R, 
Pamuklar E, Semelka RC. MRI of pregnant patients for susp-
ected pulmonary embolism: steady-state free precession vs po-
stgadolinium 3D-GRE. Acta Med Port 2012; 25: 359-367 [PMID: 
June 28, 2018|Volume 10|Issue 6|
Tsuchiya N et al . CE-MRA for the primary diagnosis of pulmonary embolism
64WJR|www.wjgnet.com June 28, 2018|Volume 10|Issue 6|
23534587]
73  Kanda T, Osawa M, Oba H, Toyoda K, Kotoku J, Haruyama T, 
Takeshita K, Furui S. High Signal Intensity in Dentate Nucleus 
on Unenhanced T1-weighted MR Images: Association with Li-
near versus Macrocyclic Gadolinium Chelate Administration. 
Radiology 2015; 275: 803-809 [PMID: 25633504 DOI: 10.1148/
radiol.14140364]
74  Gulani V, Calamante F, Shellock FG, Kanal E, Reeder SB; 
International Society for Magnetic Resonance in Medicine. 
Gadolinium deposition in the brain: summary of evidence and 
recommendations. Lancet Neurol 2017; 16: 564-570 [PMID: 
28653648 DOI: 10.1016/S1474-4422(17)30158-8]
75  Aime S, Caravan P. Biodistribution of gadolinium-based contrast 
agents, including gadolinium deposition. J Magn Reson Imaging 
2009; 30: 1259-1267 [PMID: 19938038 DOI: 10.1002/jmri.21969]
76  Nagle SK, Schiebler ML, Repplinger MD, François CJ, Vigen KK, 
Yarlagadda R, Grist TM, Reeder SB. Contrast enhanced pulmonary 
magnetic resonance angiography for pulmonary embolism: Bui-
lding a successful program. Eur J Radiol 2016; 85: 553-563 [PMID: 
26860667 DOI: 10.1016/j.ejrad.2015.12.018]
77  Maki JH, Prince MR, Londy FJ, Chenevert TL. The effects of 
time varying intravascular signal intensity and k-space acquisition 
order on three-dimensional MR angiography image quality. J 
Magn Reson Imaging 1996; 6: 642-651 [PMID: 8835958 DOI: 
10.1002/jmri.1880060413]
78  Finn JP, Nguyen KL, Hu P. Ferumoxytol vs. Gadolinium agents 
for contrast-enhanced MRI: Thoughts on evolving indications, 
risks, and benefits. J Magn Reson Imaging 2017; 46: 919-923 
[PMID: 28160356 DOI: 10.1002/jmri.25580]
79  Ripley B, Wilson GJ, Lalwani N, Briller N, Neligan PC, Maki JH. 
Initial Clinical Experience with Dual-Agent Relaxation Contrast 
for Isolated Lymphatic Channel Mapping. Radiology 2018; 286: 
705-714 [PMID: 28934015 DOI: 10.1148/radiol.2017170241]
80  Skeith L, Rodger MA. Pulmonary Complications of Pregnancy: 
Venous Thromboembolism. Semin Respir Crit Care Med 2017; 38: 
135-147 [PMID: 28561245 DOI: 10.1055/s-0037-1602241]
81  Tromeur C, van der Pol LM, Klok FA, Couturaud F, Huisman 
MV. Pitfalls in the diagnostic management of pulmonary embolism 
in pregnancy. Thromb Res 2017; 151 Suppl 1: S86-S91 [PMID: 
28262243 DOI: 10.1016/S0049-3848(17)30075-0]
82  Leung AN, Bull TM, Jaeschke R, Lockwood CJ, Boiselle PM, 
Hurwitz LM, James AH, McCullough LB, Menda Y, Paidas MJ, 
Royal HD, Tapson VF, Winer-Muram HT, Chervenak FA, Cody 
DD, McNitt-Gray MF, Stave CD, Tuttle BD; ATS/STR Committee 
on Pulmonary Embolism in Pregnancy. American Thoracic Society 
documents: an official American Thoracic Society/Society of 
Thoracic Radiology Clinical Practice Guideline--Evaluation of 
Suspected Pulmonary Embolism in Pregnancy. Radiology 2012; 
262: 635-646 [PMID: 22282185 DOI: 10.1148/radiol.11114045]
83  Wan T, Skeith L, Karovitch A, Rodger M, Le Gal G. Guidance 
for the diagnosis of pulmonary embolism during pregnancy: Cons-
ensus and controversies. Thromb Res 2017; 157: 23-28 [PMID: 
28686913 DOI: 10.1016/j.thromres.2017.06.025]
84  Sommer G, Bauman G, Koenigkam-Santos M, Draenkow C, 
Heussel CP, Kauczor HU, Schlemmer HP, Puderbach M. Non-
contrast-enhanced preoperative assessment of lung perfusion in 
patients with non-small-cell lung cancer using Fourier decom-
position magnetic resonance imaging. Eur J Radiol 2013; 82: 
e879-e887 [PMID: 24041434 DOI: 10.1016/j.ejrad.2013.06.030]
85  Ray JG, Vermeulen MJ, Bharatha A, Montanera WJ, Park AL. 
Association Between MRI Exposure During Pregnancy and Fetal 
and Childhood Outcomes. JAMA 2016; 316: 952-961 [PMID: 
27599330 DOI: 10.1001/jama.2016.12126]
86  Johns CS, Schiebler ML, Swift AJ. Commentary on: Survey of 
UK imaging practice for the investigation of pulmonary embolism 
in pregnancy. Clin Radiol 2017; 72: 702-703 [PMID: 28545683 
DOI: 10.1016/j.crad.2017.04.018]
87  van Mens TE6FKHUHV/-GH-RQJ3*/HHÀDQJ001LMNHXWHU0
Middeldorp S. Imaging for the exclusion of pulmonary embolism 
in pregnancy. Cochrane Database Syst Rev 2017; 1: CD011053 
[PMID: 28124411 DOI: 10.1002/14651858.CD011053.pub2]
88  Bannas P, Schiebler ML, Motosugi U, François CJ, Reeder SB, 
Nagle SK. Pulmonary MRA: differentiation of pulmonary embo-
lism from truncation artefact. Eur Radiol 2014; 24: 1942-1949 
[PMID: 24863886 DOI: 10.1007/s00330-014-3219-5]
89  Schiebler ML, Ahuja J, Repplinger MD, François CJ, Vigen 
KK, Grist TM, Hamedani AG, Reeder SB, Nagle SK. Incidence 
of actionable findings on contrast enhanced magnetic resonance 
angiography ordered for pulmonary embolism evaluation. Eur J 
Radiol 2016; 85: 1383-1389 [PMID: 27423676 DOI: 10.1016/
j.ejrad.2016.05.008]
90  Richman PB, Courtney DM, Friese J, Matthews J, Field A, Petri 
5.OLQH-$3UHYDOHQFHDQGVLJQL¿FDQFHRIQRQWKURPERHPEROLF
findings on chest computed tomography angiography performed 
to rule out pulmonary embolism: a multicenter study of 1,025 
emergency department patients. Acad Emerg Med 2004; 11: 
642-647 [PMID: 15175202 DOI: 10.1197/j.aem.2003.12.021]
91  Benson DG, Schiebler ML, Nagle SK, François CJ. Magnetic Res-
onance Imaging for the Evaluation of Pulmonary Embolism. Top 
Magn Reson Imaging 2017; 26: 145-151 [PMID: 28777163 DOI: 
10.1097/RMR.0000000000000133]
92  Le Gal G, Righini M, Parent F, van Strijen M, Couturaud F. Diag-
nosis and management of subsegmental pulmonary embolism. 
J Thromb Haemost 2006; 4: 724-731 [PMID: 16634736 DOI: 
10.1111/j.1538-7836.2006.01819.x]
93  Sheh SH, Bellin E, Freeman KD, Haramati LB. Pulmonary 
embolism diagnosis and mortality with pulmonary CT angiography 
versus ventilation-perfusion scintigraphy: evidence of overdiagnosis 
with CT? AJR Am J Roentgenol 2012; 198: 1340-1345 [PMID: 
22623546 DOI: 10.2214/AJR.11.6426]
94  Gómez-Sánchez MA:KDWLVWKHFOLQLFDOVLJQL¿FDQFHRILVRODWHG
subsegmental pulmonary embolism? Rev Port Pneumol 2014; 20: 
179-180 [PMID: 24931345 DOI: 10.1016/j.rppneu.2014.05.001]
95  den Exter PL, van Es J, Klok FA, Kroft LJ, Kruip MJ, 
Kamphuisen PW, Büller HR, Huisman MV. Risk profile and 
clinical outcome of symptomatic subsegmental acute pulmonary 
embolism. Blood 2013; 122: 1144-1149; quiz 1329 [PMID: 
23736701 DOI: 10.1182/blood-2013-04-497545]
96  Carrier M, Klok FA. Symptomatic subsegmental pulmonary 
embolism: to treat or not to treat? Hematology Am Soc Hematol 
Educ Program 2017; 2017: 237-241 [PMID: 29222261 DOI: 
10.1182/asheducation-2017.1.237]
97  Kearon C, Akl EA, Ornelas J, Blaivas A, Jimenez D, Bounameaux 
H, Huisman M, King CS, Morris TA, Sood N, Stevens SM, Vintch 
JRE, Wells P, Woller SC, Moores L. Antithrombotic Therapy 
for VTE Disease: CHEST Guideline and Expert Panel Report. 
Chest 2016; 149: 315-352 [PMID: 26867832 DOI: 10.1016/
j.chest.2015.11.026]
98  Ende-Verhaar YM, Cannegieter SC, Vonk Noordegraaf A, 
Delcroix M, Pruszczyk P, Mairuhu AT, Huisman MV, Klok FA. 
Incidence of chronic thromboembolic pulmonary hypertension 
after acute pulmonary embolism: a contemporary view of the 
published literature. Eur Respir J 2017; 49: [PMID: 28232411 
DOI: 10.1183/13993003.01792-2016]
99  Cronin P, Dwamena BA. A Clinically Meaningful Interpretation 
of the Prospective Investigation of Pulmonary Embolism Diagnosis 
(PIOPED) II and III Data. Acad Radiol 2018; 25: 561-572 [PMID: 
29337091 DOI: 10.1016/j.acra.2017.11.014]
P- Reviewer: Aday AW, Qi X    S- Editor: Ji FF    L- Editor: A 
E- Editor: Tan WW 
Tsuchiya N et al . CE-MRA for the primary diagnosis of pulmonary embolism
                                      © 2018 Baishideng Publishing Group Inc. All rights reserved.
Published by Baishideng Publishing Group Inc
7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA
Telephone: +1-925-223-8242
Fax: +1-925-223-8243
(PDLOESJRIÀFH#ZMJQHWFRP
+HOS'HVNKWWSZZZISXEOLVKLQJFRPKHOSGHVN
KWWSZZZZMJQHWFRP
